Mutagen sensitivity: Enhanced risk assessment of squamous cell carcinoma

European Journal of Cancer Part B: Oral Oncology - Tập 32 - Trang 367-372 - 1996
J. Cloos1, C.B.A. Reid1, G.B. Snow1, B.J.M. Braakhuis1
1Department of Otolaryngology/Head and Neck Surgery, Free University Hospital, P.O. Box 7057, 1007 MB Amsterdam, The Netherlands

Tài liệu tham khảo

Muir, 1995, Upper aerodigestive tract cancers, Cancer, 75, 147, 10.1002/1097-0142(19950101)75:1+<147::AID-CNCR2820751304>3.0.CO;2-U Barnes, 1985, Disease of the nose, paranasal sinuses and nasopharynx, 403 Vokes, 1993, Head and neck cancer, New Engl J Med, 328, 184, 10.1056/NEJM199301213280306 Blitzer, 1988, Epidemiology of head and neck cancer, Semin Oncol, 15, 2 De Vries, 1990, Magnitude of the problem, 1 Slaughter, 1953, “Field cancerization” in oral stratified squamous epithelium: clinical implications of multicentric origin, Cancer, 6, 963, 10.1002/1097-0142(195309)6:5<963::AID-CNCR2820060515>3.0.CO;2-Q Hittelman, 1991, The chromosome view of “field cancerization” and multistep car- cinogenesis. Implications for chemopreventive approaches, 41 Snow, 1991, Follow-up in patients treated for head and neck cancer: how frequent, how thorough and for how long, Eur J Cancer, 28, 315, 10.1016/S0959-8049(05)80042-5 Bongers, 1995, Second primary head and neck squamous cell carcinoma predicted by the glutathione S-transferase expression in healthy tissue in the direct vicinity of the first tumor, Lab Invest, 73, 503 Copper, 1993, A panel of biomarkers of carcinogenesis of the upper aerodigestive tract as potential intermediate endpoints in chemoprevention trials, Cancer, 71, 825, 10.1002/1097-0142(19930201)71:3<825::AID-CNCR2820710327>3.0.CO;2-X Day, 1994, Second cancers following oral and pharyngeal cancers: role of tobacco and alcohol, J Natl Cancer Inst, 86, 131, 10.1093/jnci/86.2.131 Kune, 1993, Oral and pharyngeal cancer diet, smoking, alcohol, and serum vitamin-A and beta carotene levels—a case-control study in men, Nutr Cancer, 20, 61, 10.1080/01635589309514271 DeLuca, 1993, Retinoids and their receptors in differentiation, embryogenesis and neoplasia, FASEB J, 5, 2924, 10.1096/fasebj.5.14.1661245 Flora, 1991, Prevention by N-acetyl-cysteine of benzo(a)pyrene clastogenicity and DNA adducts in rats, Mutat Res, 250, 87, 10.1016/0027-5107(91)90165-K Izzotti, 1995, Inhibition by N-acetylcysteine of carcinogen-DNA adducts in the tracheal epithelium of rats exposed to cigarette smoke, Carcinogenesis, 16, 669, 10.1093/carcin/16.3.669 Albini, 1995, Inhibition of invasion, gelatinase activity, tumor take and metastasis of malignant cells by N-acetylcysteine, Int J Cancer, 61, 121, 10.1002/ijc.2910610121 Moon, 1983, Inhibition of carcinogenesis by retinoids, Cancer Res, 43, 2469s Hill, 1992, Retinoids and cancer prevention, Annu Rev Nutr, 12, 161, 10.1146/annurev.nu.12.070192.001113 Shalinsky, 1995, Retinoid-induced suppression of squamous cell differentiation in human oral squamous cell carcinoma xenografts (Line 1483) in athymic nude mice, Cancer Res, 55, 3183 Hong, 1990, Prevention of second primary tumors in squamous cell carcinoma of the head and neck, New Engl J Med, 323, 975, 10.1056/NEJM199009203231205 Benner, 1994, Prevention of 2nd primary tumors with isotretinoin in patients with squamous cell carcinoma of the head and neck—long-term follow-up, J Natl Cancer Inst, 86, 140, 10.1093/jnci/86.2.140 De Vries, 1992, Chemoprevention in the management of oral cancer: EUROSCAN and other studies, Oral Oncol, 28B, 153, 10.1016/0964-1955(92)90045-3 1994, The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers, New Engl J Med, 330, 1029, 10.1056/NEJM199404143301501 Morse, 1993, Cancer chemoprevention: Principles and prospects, Carcinogenesis, 14, 1737, 10.1093/carcin/14.9.1737 Lippman, 1994, Epidemiology, biology, and chemoprevention of aerodigestive cancer, Cancer, 74, 2719, 10.1002/1097-0142(19941101)74:9+<2719::AID-CNCR2820741822>3.0.CO;2-N Larsson, 1991, Reactivity against herpes simplex virus in patients with head and neck cancer, Int J Cancer, 49, 14, 10.1002/ijc.2910490104 Fouret, 1995, Human papillomavirus infection in the malignant and premalignant head and neck epithelium, Diagn Mol Pathol, 4, 122, 10.1097/00019606-199506000-00008 Muscat, 1992, Tobacco, alcohol, asbestos, and occupational risk factors for laryngeal cancer, Cancer, 69, 2244, 10.1002/1097-0142(19920501)69:9<2244::AID-CNCR2820690906>3.0.CO;2-O Maier, 1991, Occupational exposure to hazardous substances and the risk of cancer in the area of the mouth cavity, oropharynx, hypopharynx and larynx. A case-control study, Laryngol Rhinol Otol, 70, 93, 10.1055/s-2007-997996 La Vecchia, 1993, Diet and human oral carcinoma in Europe, Oral Oncol, Eur J Cancer, 29B, 17, 10.1016/0964-1955(93)90005-Y Zheng, 1993, Serum micronutrients and the subsequent risk of oral and pharyngeal cancer, Cancer Res, 53, 795 Garewal, 1993, Beta-carotene and vitamin E in oral cancer prevention, J Cell Biochem (Suppl), 17F, 262, 10.1002/jcb.240531039 Wynder, 1994, Smoking and lung cancer: scientific challenges and opportunities, Cancer Res, 54, 5284 Kato, 1994, Alcohol in the aetiology of upper aerodigestive tract cancer, Oral Oncol, Eur J Cancer, 30B, 75, 10.1016/0964-1955(94)90056-6 Ng, 1993, Oral cavity cancer in non-users of tobacco, J Natl Cancer Inst, 85, 743, 10.1093/jnci/85.9.743 Spitz, 1988, Squamous cell carcinoma of the upper aerodigestive tract, Cancer, 61, 203, 10.1002/1097-0142(19880101)61:1<203::AID-CNCR2820610134>3.0.CO;2-6 Maier, 1992, Tobacco and alcohol and the risk of head and neck cancer, Clin Invest, 70, 320, 10.1007/BF00184668 Harris, 1991, Chemical and physical Carcinogenesis: Advances and perspectives for the 1990s, Cancer Res, 51, 5023s Hlavica, 1994, Regulatory mechanisms in the activation of nitrogenous compounds by the cytochrome P-450 isozymes, Drug Metab Rev, 26, 325, 10.3109/03602539409029801 Bell, 1993, Genetic risk and carcinogen exposure—a common inherited defect of the carcinogen-metabolism gene glutathione S-transferase m1 (GSTM1) that increases susceptibility to bladder cancer, J Natl Cancer Inst, 85, 1159, 10.1093/jnci/85.14.1159 Nakajima, 1995, Expression and polymorphism of glutathione S-transferase in human lungs: risk factors in smoking-related lung cancer, Carcinogenesis, 16, 707, 10.1093/carcin/16.4.707 Gatti, 1994, Sixth international workshop on Ataxia telangiectasia, Cancer Res, 54, 6007 Hecht, 1992, Cancer in ataxia telangiectasia patients, Cancer Genet Cytogenet, 46, 9, 10.1016/0165-4608(90)90003-S Swift, 1990, Cancer predisposition of ataxia telangiectasia heterozygotes, Cancer Genet Cytogenet, 46, 21, 10.1016/0165-4608(90)90004-T Cortessis, 1993, Linkage analysis of DRD2, a marker linked to the ataxia-telangiectasia gene, in 64 families with premenopausal bilateral breast cancer, Cancer Res, 53, 5083 Lehmann, 1979, The response of ataxia telangiectasia cells to bleomycin, Nucleic Acids Res, 6, 1953, 10.1093/nar/6.5.1953 Taylor, 1994, Genetic and cellular features of ataxia telangiectasia, Int J Radiat Biol, 65, 65, 10.1080/09553009414550091 Gantt, 1986, Biochemical evidence for deficient DNA repair leading to enhanced G2 chromatid radiosensitivity and susceptibility to cancer, Radiat Res, 108, 117, 10.2307/3576817 Scott, 1994, Genetic predisposition in breast cancer, Lancet, 344, 1444, 10.1016/S0140-6736(94)90615-7 Hsu, 1983, Genetic instability in the human population: a working hypothesis, Hereditas, 98, 1, 10.1111/j.1601-5223.1983.tb00574.x Pryar, 1982, Cigarette smoke and the involvement of free radical reactions in chemical carcinogenesis, Ann NY Acad Sci, 393, 1 Hsu, 1985, Differential mutagen susceptibility in cultured lymphocytes of normal individuals and cancer patients, Cancer Genet Cytogenet, 17, 307, 10.1016/0165-4608(85)90114-1 Hsu, 1987, Genetic predisposition to cancer with special reference to mutagen sensitivity, In Vitro Cell Devel Biol, 23, 591, 10.1007/BF02621067 Hsu, 1989, Sensitivity to genotoxic effects of bleomycin in humans: possible relationship to environmental Carcinogenesis, Int J Cancer, 43, 403, 10.1002/ijc.2910430310 Schantz, 1989, Mutagen-induced chromosome fragility within peripheral blood lymphocytes of head and neck cancer patients, Head Neck, 11, 337, 10.1002/hed.2880110409 Cloos, 1994, Increased mutagen sensitivity in head and neck squamous cell carcinoma patients, particularly those with multiple primary tumors, Int J Cancer, 56, 816, 10.1002/ijc.2910560610 Spitz, 1995, Mutagen sensitivity and wood dust exposure in lung cancer: a case—control analysis, 36, 280 Hagmar, 1994, Cancer risk in humans predicted by increased levels of chromosomal aberrations in lymphocytes: Nordic study group on the health risk of chromosomal damage, Cancer Res, 54, 2919 Li, 1990, Differential bleomycin susceptibility in cultured lymphocytes of fragile X patients and normal individuals, Human Genet, 85, 267, 10.1007/BF00206743 Ning, 1992, Heterozygote detection through bleomycin-induced G2 chromatid breakage in dyskeratosis congenital families, Cancer Genet Cytogenet, 60, 31, 10.1016/0165-4608(92)90229-2 Sanford, 1989, Factors affecting and significance of G2 chromatin radiosensitivity in predisposition to cancer, Int J Radial Biol, 55, 963, 10.1080/09553008914551001 Knight, 1993, X-ray-induced chromatid damage in relation to DNA repair and cancer incidence in family members, Int J Cancer, 54, 589, 10.1002/ijc.2910540412 Liang, 1989, Mutagen sensitivity and cancer susceptibility. Report of a cancer prone family, Cancer, 64, 1474, 10.1002/1097-0142(19891001)64:7<1474::AID-CNCR2820640719>3.0.CO;2-S Bondy, 1993, Association between family history of cancer and mutagen sensitivity in upper aerodigestive tract cancer patients, Cancer Epidemiol Biomarkers & Prev, 2, 103 Schantz, 1989, Young adults with head and neck cancer express increased susceptibility to mutagen-induced chromosome damage, JAMA, 262, 3313, 10.1001/jama.1989.03430230098033 Hsu, 1991, Mutagen sensitivity: a biological marker of cancer susceptibility, Cancer Epid Biomarkers & Prev, 1, 83 Schantz, 1990, Mutagen sensitivity in patients with head and neck cancers: a biological marker for risk of multiple primary malignancies, J Natl Cancer Inst, 82, 1773, 10.1093/jnci/82.22.1773 Spitz, 1994, Mutagen sensitivity as a risk factor for second malignant tumors following malignancies of the upper aerodigestive tract, J Natl Cancer Inst, 86, 1681, 10.1093/jnci/86.22.1681 Dave, 1994, Nonrandom distribution of mutagen-induced chromosome breaks in lymphocytes of patients with different malignancies, Int J Oncol, 5, 733 Wu, 1995, Survival of bleomycin-induced chromosomal lesions in cultured lymphocytes and its association with lung cancer, 36, 275 Caporaso, 1995, Cancer genes: single and susceptibility: Exposing the difference, Pharmacogenetics, 61, 480 Cloos, 1996, Genetic susceptibility to head and neck squamous cell carcinoma, J Natl Cancer Inst, 88, 530, 10.1093/jnci/88.8.530 Spitz, 1995, Mutagen sensitivity as a biological marker of lung cancer risk in African Americans, Cancer Epidemiol Biomarkers & Prev, 4, 99 West, 1994, Normal cell radiosensitivity: clinical application in predicting response to radiotherapy and cancer predisposition, Int J Radiat Biol, 66, 231, 10.1080/09553009414551151 Pollak, 1995, Correspondence Re: Mutagen sensitivity as a risk factor for second malignant tumors following malignancies of the upper aerodigestive tract, J Natl Cancer Inst, 87, 458, 10.1093/jnci/87.6.458 Spitz, 1995, Response to correspondence, J Natl Cancer Inst, 87, 458, 10.1093/jnci/87.6.458-a Olden, 1994, Mutagen hypersensitivity as a biomarker of genetic predisposition to carcinogenesis, J Natl Cancer Inst, 86, 1660, 10.1093/jnci/86.22.1660 Hecht, 1994, Environmental tobacco smoke and lung cancer: the emerging role of carcinogen biomarkers and molecular epidemiology, J Natl Cancer Inst, 86, 1369, 10.1093/jnci/86.18.1369